Klajda-Nowak K
Klinika Patologii i Intensywnej Terapii Noworodka, Instytut Matki i Dziecka w Warszawie, ul. Kasprzaka 17a, 01-211 Warszawa, Polska.
Med Wieku Rozwoj. 2000;4(2 Suppl 3):97-103.
The aim of the study was to assess the effectiveness of the clinical risk index (CRIB) for the prognosis survival of newborns with low birth weight. The examined group consisted of 69 newborns who were admitted to the Clinical Department of Neonatal Pathology and Intensive Care at the National Institute of Mother and Child in Warsaw. The newborn babies were of less than 31 Hbd gestational age and less than 1501 g birth weight. The group of newborns was divided into 3 subgroups according to the level of the CRIB index. Gestational age, birth weight, Apgar score, use of prenatal steroids, introduction of surfactant supply and newborn survival were estimated. The CRIB score proved to be useful in anticipating the survival of newborns with critically low birth weight. The higher the CRIB score, the lower was the expectation for survival. The close relation of the CRIB score with gestational age, birth weight and Apgar score was proved. The indication for introduction of surfactant depends both on the newborn's clinical condition and on the CRIB score as well.
本研究的目的是评估临床风险指数（CRIB）对低出生体重新生儿预后生存的有效性。研究组由69名新生儿组成，他们被收治于华沙国家母婴研究所新生儿病理学与重症监护临床科室。这些新生儿的胎龄小于31周，出生体重小于1501克。根据CRIB指数水平，将新生儿组分为3个亚组。对胎龄、出生体重、阿氏评分、产前类固醇的使用、表面活性剂供应的引入以及新生儿生存情况进行了评估。CRIB评分被证明对预测极低出生体重新生儿的生存情况有用。CRIB评分越高，生存期望越低。证明了CRIB评分与胎龄、出生体重和阿氏评分密切相关。表面活性剂引入的指征既取决于新生儿的临床状况，也取决于CRIB评分。
